Publications by authors named "Fujing Ge"

Claim this Profile
D
Deubiquitinating enzyme JOSD2 modulates cGAS to facilitate immune evasion in colorectal cancer.
Jiamin Du, Yiqun Fan, Junwei Fu, Fujing Ge, Hongdao Zhu

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC.
Fujing Ge, Hongdao Zhu, Xiangning Liu, Yuekang Li, Runqiu Guo

Cell Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting VCP enhances colorectal cancer therapy through STING stabilization.
Hongdao Zhu, Fujing Ge, Jingyu Dai, Shuyu Yang, Tao Yuan

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAT1 Enhances the Sensitivity of Non-Small Cell Lung Cancer to VCP Inhibitors by Regulating the Activation of the Endoplasmic Reticulum Stress Pathway.
Xiangning Liu, Peiying Zhang, Fujing Ge, Tao Yuan, Runqiu Guo

FASEB J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis.
Yue-Kang Li, Fu-Jing Ge, Xiang-Ning Liu, Chen-Ming Zeng, Mei-Jia Qian

Acta Pharmacol Sin· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UniMap: Type-Level Integration Enhances Biological Preservation and Interpretability in Single-Cell Annotation.
Haitao Hu, Yue Guo, Fujing Ge, Hao Yin, Hao Zhang

Adv Sci (Weinh)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer.
Tao Yuan, Yue Liu, Ruilin Wu, Meijia Qian, Weihua Wang, Fujing Ge

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JOSD2 promotes breast cancer metastasis by deubiquitinating and stabilizing SMAD4.
Jiamin Du, Jiao Wang, Fujing Ge, Hongrui Ma, Hongdao Zhu

Biochem Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient.
Fu-Jing Ge, Xiao-Yang Dai, Yao Qiu, Xiang-Ning Liu, Chen-Ming Zeng

Acta Pharmacol Sin· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4/MMP11 signalling axis.
Fujing Ge, Chenming Zeng, Jiaer Wang, Xiangning Liu, Churun Zheng

Biochim Biophys Acta Mol Basis Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity.
Tao Yuan, Chenming Zeng, Jiawei Liu, Chenxi Zhao, Fujing Ge

Signal Transduct Target Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deubiquitinating enzyme JOSD2 affects susceptibility of non-small cell lung carcinoma cells to anti-cancer drugs through DNA damage repair.
Fujing Ge, Xiangning Liu, Hongyu Zhang, Tao Yuan, Hong Zhu

Zhejiang Da Xue Xue Bao Yi Xue Ban· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of PLK1 inhibitor in osimertinib resistant non-small cell lung carcinoma cells.
Xiaoyang Dai, Xiangning Liu, Fujing Ge, Hongdao Zhu, Churun Zheng

Zhejiang Da Xue Xue Bao Yi Xue Ban· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deubiquitinating enzymes: Promising targets for drug resistance.
Fujing Ge, Yuekang Li, Tao Yuan, Yulian Wu, Qiaojun He

Drug Discov Today· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular mechanisms and targeting strategies of transcription factors in cholangiocarcinoma.
Jiao Wang, Fujing Ge, Tao Yuan, Meijia Qian, Fangjie Yan

Expert Opin Ther Targets· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner.
Lin-Lin Chang, Yue-Kang Li, Chen-Xi Zhao, Chen-Ming Zeng, Fu-Jing Ge

Acta Pharmacol Sin· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The calcimimetic agent cinacalcet inhibits hepatocellular carcinoma via YAP/TAZ suppression.
Lin Zheng, Jiamin Du, Fujing Ge, Meijia Qian, Bo Yang

Pharmazie· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Emissive Platinum(II) Metallacage with a Sensitive Oxygen Response for Imaging of Hypoxia and Imaging-Guided Chemotherapy.
Huangtianzhi Zhu, Qi Li, Bingbing Shi, Fujing Ge, Yuezhou Liu

Angew Chem Int Ed Engl· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets.
Chenming Zeng, Chenxi Zhao, Fujing Ge, Yuekang Li, Ji Cao

Front Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis